Previous Article | Next Article ![]()
Infection and Immunity, January 2001, p. 307-314, Vol. 69, No. 1
Edward Mallinckrodt Department of Pediatrics
and Department of Molecular Microbiology, Washington University School
of Medicine, and Division of Infectious Diseases, St. Louis Children's
Hospital, St. Louis, Missouri 63110
Received 4 August 2000/Accepted 1 October 2000
Nontypeable Haemophilus influenzae is an important
cause of localized respiratory tract disease, which begins with
colonization of the upper respiratory mucosa. In previous work we
reported that the nontypeable H. influenzae HMW1 and HMW2
proteins are high-molecular-weight nonpilus adhesins responsible for
attachment to human epithelial cells, an essential step in the process
of colonization. Interestingly, although HMW1 and HMW2 share
significant sequence similarity, they display distinct cellular binding
specificities. In order to map the HMW1 and HMW2 binding domains, we
generated a series of complementary HMW1-HMW2 chimeric proteins and
examined the ability of these proteins to promote in vitro adherence by Escherichia coli DH5
0019-9567/01/$04.00+0 DOI: 10.1128/IAI.69.1.307-314.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.
Mapping of Binding Domains of Nontypeable
Haemophilus influenzae HMW1 and HMW2 Adhesins
. Using this approach, we localized
the HMW1 and HMW2 binding domains to an ~360-amino-acid region near
the N terminus of the mature HMW1 and HMW2 proteins. Experiments with maltose-binding protein fusion proteins containing segments of either
HMW1 or HMW2 confirmed these results and suggested that the fully
functional binding domains may be conformational structures that
require relatively long stretches of sequence. Of note, the HMW1 and
HMW2 binding domains correspond to areas of maximal sequence dissimilarity, suggesting that selective advantage associated with
broader adhesive potential has been a major driving force during
H. influenzae evolution. These findings should facilitate efforts to develop a subcomponent vaccine effective against nontypeable H. influenzae disease.
*
Corresponding author. Mailing address: Department of
Pediatrics, Washington University School of Medicine, 660 South Euclid Ave., Box 8208, St. Louis, MO 63110. Phone: (314) 286-2887. Fax: (314)
286-2895. E-mail: stgeme{at}borcim.wustl.edu.
This article has been cited by other articles:
| J. Bacteriol. | J. Virol. | Eukaryot. Cell |
|---|
| Microbiol. Mol. Biol. Rev. | Clin. Vaccine Immunol. | All ASM Journals |
|---|